Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs Aspirin in ACS (GEMINI ACS 1)
NCT02293395Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Apr 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 2 trial of rivaroxaban in acute coronary syndrome (ACS), sponsored by Janssen Pharmaceutical. Started Apr 2015; status: completed.
02
Drugs
rivaroxaban
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02293395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02293395.